HomeNPCE • NASDAQ
add
Neuropace Inc
Previous close
$10.04
Day range
$9.56 - $10.42
Year range
$5.45 - $15.70
Market cap
309.23M USD
Avg Volume
302.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 21.47M | 19.18% |
Operating expense | 19.84M | 6.69% |
Net income | -5.25M | 15.32% |
Net profit margin | -24.46 | 28.94% |
Earnings per share | -0.18 | 21.74% |
EBITDA | -3.60M | 28.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 52.76M | -20.61% |
Total assets | 94.65M | -12.08% |
Total liabilities | 86.63M | -0.42% |
Total equity | 8.01M | — |
Shares outstanding | 32.56M | — |
Price to book | 37.19 | — |
Return on assets | -9.57% | — |
Return on capital | -11.09% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -5.25M | 15.32% |
Cash from operations | -4.80M | -43.58% |
Cash from investing | 1.96M | -43.45% |
Cash from financing | 848.00K | -89.68% |
Net change in cash | -1.99M | -123.83% |
Free cash flow | -3.10M | -52.99% |
About
Founded
1997
Website
Employees
184
